相关实验视频
Updated: Jul 6, 2025
08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.3K
循环RNAs在乳腺癌诊断,治疗和预后中的作用
Xiaojia Huang1, Cailu Song2, Jinhui Zhang2
1Department of Breast Oncology Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, China.
Oncology research
|January 8, 2024
概括
循环RNAs (circRNAs) 是乳腺癌的关键调节者,影响瘤生长和治疗耐药性. 了解circRNA机制为乳腺癌管理提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳腺癌是全球最常见的恶性瘤,对公众健康构成重大挑战.
- 循环RNAs (circRNAs) 是一种非编码RNAs (ncRNAs) 的新型类型,在癌症发展中起着关键作用.
- circRNAs与乳腺癌的发病,进展,复发和多药性耐药性有关.
研究的目的:
- 审查最近关于乳腺癌中circRNAs生物合成和特征的研究.
- 评估circRNAs作为生物标志物和治疗点的临床应用.
- 探索circRNAs在改变乳腺癌诊断,治疗和预后方面的潜力.
主要方法:
- 关于乳腺癌中circRNAs最近研究的文献综述.
- 对circRNA生物合成,特征和作用机制的分析.
- 在诊断,治疗,预后和治疗策略中评估circRNAs.
主要成果:
- circRNAs在乳腺癌瘤发生和进展中起着重要作用.
- circRNAs具有作为诊断和预后生物标志物的潜力.
- circRNAs可以调解乳腺癌中的多药耐药性.
- circRNAs代表了新型治疗干预措施的有希望的目标.
结论:
- 循环RNA在乳腺癌中至关重要,影响从发病到治疗耐药性的各种方面.
- 进一步了解circRNA功能可以带来更好的临床应用.
- 基于circRNA的策略有望促进乳腺癌的管理和治疗.
相关概念视频
02:55The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:21Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355